Solara Active Pharma Sciences posts consolidated Q2 FY2024 loss at Rs. 17.16 Cr
Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023
Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023
US business grew by +12.8% YoY
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Total transaction value of the divestment is Rs. 3,660 million
PhytoSquene now available for clinical and commercial use
Gland Pharma has reported total income of Rs. 1426.57 crores during the period ended September 30, 2023
Sun Pharma Advanced Research Company Limited has reported total income of Rs. 29.67 crores during the period ended September 30, 2023
Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023
Divi's Laboratories Limited has reported total income of Rs. 1995 crores during the period ended September 30, 2023
Zydus Wellness has reported total income of Rs. 444 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated